Brief: Oasmia Pharmaceutical Q3 Oper Loss Narrows To SEK 28.6 Mln

Vivesto AB

19/02/2021 07:19

Feb 19 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * YEAR-END REPORT 1  FOR THE SHORTENED 2  FINANCIAL YEAR MAY
1,
2020 – DECEMBER 31, 2020
    * Q3 CONSOLIDATED NET SALES AMOUNTED TO TSEK 120 (132)
    * Q3 OPERATING PROFIT/LOSS WAS TSEK -28,580 (-34,056)

Source text for Eikon:  ID:nMFNbn8w8Z 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))